Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis

[1] Garcia-Tsao G(2008)Acute kidney injury in cirrhosis Hepatology 48 2064-2077

[2] Parikh CR(2003)Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management J Hepatol 38 S69-S89

[3] Viola A(2008)Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome a randomized study Gastroenterology 134 1352-1359

[4] Arroyo V(2007)Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias Am J Transplant 7 685-692

[5] Colmenero J(2008)Pathogenesis and treatment of hepatorenal syndrome Semin Liver Dis 28 81-95

[6] Martin-Llahi M(2010)The evaluation of renal function and disease in patients with cirrhosis J Hepatol 52 605-613

[7] Pepin MN(1995)Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine for glomerular filtration rate Kidney Int 47 312-318

[8] Guevara M(2002)Plasma cystatin C as a marker of renal function in patients with liver cirrhosis Scand J Clin Lab Invest 62 129-134

[9] Cholongitas E(2005)Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans Scand J Clin Lab Invest 65 111-124

[10] Marelli L(2001)Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome Clin Chim Acta 2 81-89

[1] Garcia-Tsao G(2008)Acute kidney injury in cirrhosis Hepatology 48 2064-2077

[2] Parikh CR(2003)Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management J Hepatol 38 S69-S89

[3] Viola A(2008)Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome a randomized study Gastroenterology 134 1352-1359

[4] Arroyo V(2007)Female liver transplant recipients with the same GFR as male recipients have lower MELD scores—a systematic bias Am J Transplant 7 685-692

[5] Colmenero J(2008)Pathogenesis and treatment of hepatorenal syndrome Semin Liver Dis 28 81-95

[6] Martin-Llahi M(2010)The evaluation of renal function and disease in patients with cirrhosis J Hepatol 52 605-613

[7] Pepin MN(1995)Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine for glomerular filtration rate Kidney Int 47 312-318

[8] Guevara M(2002)Plasma cystatin C as a marker of renal function in patients with liver cirrhosis Scand J Clin Lab Invest 62 129-134

[9] Cholongitas E(2005)Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans Scand J Clin Lab Invest 65 111-124

[10] Marelli L(2001)Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome Clin Chim Acta 2 81-89